Telemedicine Reports

Telemedicine Reports is a gold open access journal for telemedicine, telehealth and digital health, started in 2020 and published by SAGE Publications since 2026, with a 2025 Journal Impact Factor of 1.9 and a place in the third quartile of Health Care Sciences and Services at 128 of 194.《远程医疗报告》（Telemedicine Reports）是金色开放获取期刊，面向远程医疗、远程健康与数字健康，2020 年创刊，2026 年起由 SAGE Publications 出版，2025 年影响因子 1.9，在卫生保健与服务类目列第三四分位，排名 128/194。

Its remit is practical. Papers describe what happened when care was delivered at a distance, and the journal expects implementation detail, cost and patient outcomes alongside any claim about the technology.刊物的取材偏实用。论文交代远程交付诊疗的实际经过，除技术主张之外，还要求给出实施细节、成本与患者结局。

Scope

• The aims and scope name three strands, telemedicine research, education and implementation science, and put the weight on integrating telehealth technologies and applications into ordinary healthcare settings.宗旨与范围列明三条主线，分别为远程医疗研究、教育与实施科学，重心落在把远程健康技术与应用嵌入日常诊疗场景。
• Better efficacy, efficiency and effectiveness of care is stated as the end, and the journal ties that end to patient outcomes rather than to uptake measured on its own.刊物把提升诊疗的效力、效率与效果写作归宿，并把这一归宿系于患者结局，而不系于孤立统计的采用率。
• Remote consultation carries the most weight, covering video visits, store-and-forward messaging, eConsults between primary care and specialists, and the scheduling and workflow changes each of them forces.远程会诊分量最重，涵盖视频门诊、存储转发式消息、基层与专科之间的电子咨询，以及每一种形式带来的排班与流程改动。
• Remote monitoring and telecare for chronic disease appear in every volume, from home blood pressure and glucose transmission to remote titration of peritoneal dialysis and post-operative follow-up.慢病远程监测与远程照护每卷都有，从家庭血压与血糖上传，到腹膜透析的远程调参与术后随访。
• Teledermatology, teleophthalmology, teleradiology and telepathology supply the imaging work, and diagnostic concordance, miss rates and image quality are treated as reportable results rather than as side notes.远程皮肤科、远程眼科、远程放射与远程病理构成影像部分，诊断一致性、漏诊率与图像质量按正式结果报告，不当作附带说明。
• Telemental health is handled as a field of its own, with attention to crisis response, prescribing rules, the therapeutic relationship over video and the limits of assessment without touch.远程精神卫生另作一域处理，关注危机处置、处方规则、视频条件下的医患关系，以及无法接触患者身体所带来的评估局限。
• Mobile health, wearables and patient-generated data enter where they change a clinical decision, and studies that cannot say what the data altered tend to be sent back.移动健康、可穿戴设备与患者自采数据，凡能改变临床决策者都收，说不出数据改变了哪一步的稿件多被退回。
• Artificial intelligence and decision support belong to remote care here rather than to a separate computer science section, so validation inside a running service counts for more than a benchmark score.人工智能与决策支持归入远程诊疗，不另立计算机科学栏目，真实运行服务中的验证因此重于基准得分。
• Policy work runs through licensure, practice across jurisdictions, prescribing of controlled substances, reimbursement parity and the payment models that decide whether a programme outlives its grant.政策类稿件贯穿执业许可、跨辖区行医、管制药品处方、报销对等，以及决定项目能否走出资助期的支付模式。
• Access for rural, frontier, carceral and other underserved populations is a standing concern, and equity is usually examined by race, income, age, language and broadband availability.农村、边远、监所与其他服务不足人群的可及性是常设关切，公平问题常按族群、收入、年龄、语言与宽带条件分别考察。
• Health economics appears as cost per encounter, budget impact, cost-effectiveness and return on investment, and the payer perspective is expected to be named.卫生经济学以单次就诊成本、预算影响、成本效果与投资回报的形式出现，并要求写明支付方立场。
• Patient and clinician experience forms another strand, covering satisfaction, usability, digital literacy, workflow burden and the effect of virtual visits on continuity of care.患者与临床医生的体验另成一脉，涵盖满意度、可用性、数字素养、流程负担，以及虚拟就诊对诊疗连续性的影响。
• Privacy, security, consent, data governance and device regulation are in scope, and work on interoperability standards is accepted where a live service depends on them.隐私、安全、知情同意、数据治理与器械监管都在范围之内，服务实际依赖互操作标准的场合也收相应研究。
• Education and workforce papers describe how clinicians are trained and supported for virtual care, and the journal also prints protocols, quality improvement reports and scoping or systematic reviews.教育与人力类论文说明临床医生如何为虚拟诊疗接受训练与支持，刊物同时刊载研究方案、质量改进报告，以及范围综述与系统综述。
• Implementation science is treated as a method, so a paper is asked to name its framework, describe the adaptations made locally and report what was still running once the funding stopped.实施科学按方法对待，论文须点明所用框架、交代本地所做的调整，并报告资助停止后仍在运转的部分。

History

• The first volume is dated 2020, and Mary Ann Liebert, Inc. started the title in New Rochelle, New York, as a fully open access companion to the company's older telemedicine list.第 1 卷标为 2020 年，Mary Ann Liebert 公司在纽约新罗谢尔创办该刊，作为公司原有远程医疗刊群的全开放伴随刊。
• It appeared without a print edition. The electronic number 2692-4366 is the only identifier, and the National Library of Medicine catalogues the title as born digital.创刊即无纸本。电子刊号 2692-4366 是唯一的刊号，美国国家医学图书馆按纯电子刊编目。
• Indexing came early. PubMed lists the title from volume 1, number 1 of 2020, and the full text has been deposited in PubMed Central from the same point.收录来得早。PubMed 自 2020 年第 1 卷第 1 期起收录，全文也从同一时点起存入 PubMed Central。
• It sits beside Telemedicine and e-Health, the Liebert title that has carried its present name since 2000, and the two remain separate publications with different business models and different indexing.刊物与 Liebert 公司自 2000 年起沿用现名的《远程医疗与电子健康》并列，两者始终是各自独立的刊物，商业模式与收录状态都不相同。
• Publication is continuous. The National Library of Medicine gives the frequency as continuously updated, and Crossref shows volume 7 running across 2026 with no issue numbers and no page ranges.出版形制为连续出版。美国国家医学图书馆把频率记为持续更新，Crossref 显示第 7 卷贯穿 2026 年，既无期号也无页码区间。
• Articles therefore carry a digital object identifier and an article-level locator in place of a page span, and the annual volume is closed once the year ends.论文因此以数字对象标识符与篇级定位号代替页码区间，年度卷次在年末收口。
• Volume numbering has advanced by one a year, so volume 1 is 2020 and volume 7 is 2026, a run of 238 records in the Crossref deposit.卷号每年递增一卷，第 1 卷为 2020 年，第 7 卷为 2026 年，Crossref 存档累计 238 条记录。
• The publisher named in the record changed in 2026. The National Library of Medicine imprint now reads Thousand Oaks, California, SAGE Publications, 2026-, while the New Rochelle Liebert address is kept as the earlier imprint.记录里的出版方在 2026 年更换。美国国家医学图书馆的出版项现记为加利福尼亚州千橡市的 SAGE Publications，起始年为 2026，新罗谢尔的 Liebert 地址作为旧出版项保留。
• Crossref already records SAGE Publications as publisher, and the Directory of Open Access Journals lists SAGE Publishing with the journal home page moved onto the SAGE platform.Crossref 的出版方字段已写作 SAGE Publications，开放获取期刊目录把出版方记为 SAGE Publishing，刊物主页随之迁到 SAGE 平台。
• The Liebert journal page is still the address printed in many indexes and older reference lists, so links from the first six volumes continue to circulate.Liebert 公司的旧刊页仍是许多索引与旧参考文献印出的地址，前六卷时期的链接继续流通。
• Under SAGE the article processing charge is 2,500 US dollars for accepted work, and the model stays gold, with no subscription barrier on new content.转到 SAGE 之后，录用稿件的文章处理费为 2500 美元，模式仍为金色开放获取，新内容不设订阅门槛。
• Metrics moved upward over the same years. The Journal Impact Factor was 1.5 in 2023, 1.6 in 2024 and 1.9 in 2025, with a five-year figure of 1.9 and a Journal Citation Indicator of 0.52.指标在同期逐年上行。影响因子 2023 年为 1.5，2024 年为 1.6，2025 年为 1.9，五年影响因子 1.9，期刊引文指标 0.52。
• The 2025 census counts 48 articles against 301 citations to the run, a cited half-life of 2.7 years and a gold open access share of 98.55 per cent.2025 年统计口径下年发文 48 篇，全刊累计被引 301 次，引用半衰期 2.7 年，金色开放获取占比 98.55%。
• It is indexed in the Emerging Sources Citation Index and not in the Science Citation Index Expanded, and a Journal Impact Factor has been assigned only from the 2023 release onward.刊物收录于新兴来源引文索引，未进入科学引文索引扩展版，影响因子自 2023 年那一版起才有。
• A percentile of 34.3 in Health Care Sciences and Services puts it in the third quartile at 128 of 194, a position shaped by a small annual output as much as by citation counts.在卫生保健与服务类目的百分位为 34.3，列第三四分位，排名 128/194，这一位置既受年发文量偏小的影响，也受引用规模的影响。

Editors

• The masthead is published on the publisher's journal site, where the editor-in-chief, the associate editors and the editorial board are listed with names and affiliations.编委会名单登在出版方的期刊站点上，主编、副编辑与编委按姓名和单位分列。
• Peer review is single anonymous, as the journal's registration with the Directory of Open Access Journals records, so reviewers know who wrote a paper and authors do not learn who reviewed it.同行评审采用单向匿名，刊物在开放获取期刊目录的登记如此记载，评审人知道作者是谁，作者不知道评审人是谁。
• Manuscripts enter through the publisher's online submission system, and the author instructions set the required shape for original research, for reviews and for implementation reports separately.稿件经出版方的在线投稿系统进入，作者指南对原创研究、综述与实施报告分别规定体例。
• The first screen asks whether a service actually ran. A paper that reports a planned platform with no patients, no cost data and no outcome measure is unlikely to reach reviewers.初审先问服务是否真的跑过。只描述规划中的平台、既无患者也无成本数据与结局指标的稿件，通常到不了评审环节。
• Original research and reviews carry most of the pages, and shorter reports appear where a single service or a small evaluation is worth recording before a full study can be mounted.原创研究与综述占据多数篇幅，较短的报告见刊于单项服务或小型评估值得在完整研究之前留档的场合。
• Work on human subjects is expected to carry an ethics approval statement and a consent statement, and the approving body is named rather than left implicit.涉及人的研究须附伦理审批声明与知情同意声明，并写明批准机构，不得含糊带过。
• Evaluations of a live service are asked for a data availability statement, and trials are expected to be registered before enrolment rather than after analysis.在运行服务上做的评估须给出数据可得性声明，试验应在入组之前完成注册，而非等到分析之后。
• Papers appear in English, and the journal does not run a translation service, so a manuscript that needs heavy language work is returned before review.论文以英文发表，刊物不设翻译服务，语言上需要大改的稿件在送审之前即退回。
• Accepted articles are posted online as they are ready and take their place in the annual volume, which is why no page numbers attach to them.录用稿在就绪后即上线，随后归入年度卷次，页码因此不附着于单篇。
• Corrections and retractions follow the publisher's policy and appear as notices linked to the original article, and the original text is marked rather than deleted.更正与撤稿依出版方政策办理，以关联原文的声明形式刊出，原文作标记而不删除。
• Enquiries about fit go to the editorial office before submission, and the answer usually turns on whether the work reports a service that ran and what it cost.选题是否合适的询问在投稿前寄到编辑部，答复多取决于所报服务是否真的运行过，以及花了多少钱。